France
One Biosciences is a biotechnology startup based in France, founded in 2020. The company's slogan "Focused on generating precision medicines by leveraging the power of single-cell technologies" encapsulates their focus on leveraging single-cell analysis to unlock precision medicines for challenging conditions. One Biosciences operates as an integrated discovery engine, utilizing a multi-disciplinary team and in-house computational capabilities.
Notably, the startup is backed by Institut Curie and Home Biosciences, which provides a strong foundation for its innovative pursuits. The latest investment in October 2020 came in the form of a Non-Equity Assistance investment from AGORANOV, showcasing confidence from the investment community in the company's vision and capabilities. With a focus on biotechnology, health and wellness, and life sciences, One Biosciences is positioned at the intersection of multiple high-potential industries.
Overall, One Biosciences presents a compelling case as a startup with a promising trajectory in developing precision medicines, driven by cutting-edge single-cell technologies and bolstered by strategic partnerships and investments.
